Transurban Group (ASX:TCL) announced the progress of West Gate Tunnel Project


Toll road operator, Transurban Group (ASX:TCL) is speculated to be preparing for a potential equity raising, while it aims to continue to maintain its yield for decent returns to shareholders. Recently, Victorian Government announced the completion of the Monash Freeway Upgrade and it was observed that new lanes were opened on the Monash Freeway in May, two months ahead of schedule. It was significant development that the completion of the project extended the managed motorway system along the M1 corridor to improve traffic flow and safety. The Company’s unique integrated public-private delivery model has leveraged capabilities of both Transurban and the state to deliver the Monash Freeway Upgrade, with early realisation of benefits for the community.

This progress on the West Gate Tunnel Project was followed with planning approvals, in the form of a Planning Scheme Amendment that were passed through the Legislative Council in Victoria and the Company is expecting to complete the project over the timeframes that were announced in December. In fact, Uber is gradually chipping away by taking the advantage of Transurban Group by offering its air-taxi service, around the cities of Sydney and Melbourne as soon as 2020. The Company is planning to release its financials on 7 August 2018. The stock price was marginally up that is by 0.41 per cent and was trading at $11.99 as on 18 July 2018; 03:30 PM AEST.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report